Found: 143
Select item for more details and to access through your institution.
The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 751, doi. 10.1002/ajh.23731
- By:
- Publication type:
- Article
Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfalls.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 110, doi. 10.1002/ajh.23572
- By:
- Publication type:
- Article
Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 663, doi. 10.1002/ajh.23213
- By:
- Publication type:
- Article
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.
- Published in:
- NPJ Digital Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s41746-022-00627-4
- By:
- Publication type:
- Article
Implications of heterogeneity in multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
MMSET: role and therapeutic opportunities in multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
MicroRNA: important player in the pathobiology of multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
MMSET: Role and Therapeutic Opportunities in Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/636514
- By:
- Publication type:
- Article
MicroRNA: Important Player in the Pathobiology of Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/521586
- By:
- Publication type:
- Article
Implications of Heterogeneity in Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/232546
- By:
- Publication type:
- Article
Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 6, p. 941, doi. 10.3390/cells11060941
- By:
- Publication type:
- Article
Immunotherapy in Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 3, p. 601, doi. 10.3390/cells9030601
- By:
- Publication type:
- Article
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Qualitative Study of Factors Affecting Patient, Caregiver and Physician Preferences for Treatment of Myeloma and Indolent Lymphoma.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 301, doi. 10.2147/PPA.S241340
- By:
- Publication type:
- Article
The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 159, doi. 10.1002/cyto.b.21529
- By:
- Publication type:
- Article
Treatment horizon in multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 425, doi. 10.1111/ejh.13840
- By:
- Publication type:
- Article
The evolution of immune dysfunction in multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 415, doi. 10.1111/ejh.13839
- By:
- Publication type:
- Article
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00164-4
- By:
- Publication type:
- Article
Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.559822
- By:
- Publication type:
- Article
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 453, p. 1, doi. 10.1126/scitranslmed.aan0941
- By:
- Publication type:
- Article
NanoVar: accurate characterization of patients' genomic structural variants using low-depth nanopore sequencing.
- Published in:
- Genome Biology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s13059-020-01968-7
- By:
- Publication type:
- Article
Paraprotein interference in the diagnosis of hepatitis C infection.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Castleman's Disease Presenting as Prolonged Anemia and Growth Retardation: A Case Report and Literature Review.
- Published in:
- Acta Haematologica, 2011, v. 125, n. 3, p. 125, doi. 10.1159/000322119
- By:
- Publication type:
- Article
Vγ9Vδ2 T cells expressing a BCMA—Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0267475
- By:
- Publication type:
- Article
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261469
- By:
- Publication type:
- Article
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1207, doi. 10.3390/ijms23031207
- By:
- Publication type:
- Article
Potential Clinical Application of Genomics in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1721, doi. 10.3390/ijms19061721
- By:
- Publication type:
- Article
Necrotizing Fasciitis in Hematological Patients: Enterobacteriaceae Predominance and Limited Utility of Laboratory Risk Indicator for Necrotizing Fasciitis Score.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 2, p. 1, doi. 10.1093/ofid/ofv081
- By:
- Publication type:
- Article
P-186: Toxicity and survival outcomes of autologous stem cell transplant in Multiple Myeloma patients with renal impairment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S139, doi. 10.1016/S2152-2650(21)02313-2
- By:
- Publication type:
- Article
P-098: Super-enhancer-driven PPP1R15B as an oncogenic and potential therapeutic target in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S92, doi. 10.1016/S2152-2650(21)02232-1
- By:
- Publication type:
- Article
MM-253: Single Cell Multi-Omic Analysis And Immune Cell Type Profiling Of Multiple Myeloma With t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S432, doi. 10.1016/S2152-2650(21)01963-7
- By:
- Publication type:
- Article
Poster: MM-253: Single Cell Multi-Omic Analysis And Immune Cell Type Profiling Of Multiple Myeloma With t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01602-5
- By:
- Publication type:
- Article
Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Carfilzomib, Thalidomide and Dexamethasone (KTd) is safe and effective in RRMM: interim analysis of the single arm, multicentre phase II ALLG MM018/AMN002 study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e274, doi. 10.1016/j.clml.2019.09.452
- By:
- Publication type:
- Article
Salsalate is An Active Agent in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e135, doi. 10.1016/j.clml.2019.09.224
- By:
- Publication type:
- Article
Super-enhancer profiling of multiple myeloma in search of novel oncogenes and therapeutic targets.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e67, doi. 10.1016/j.clml.2019.09.106
- By:
- Publication type:
- Article
Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e60, doi. 10.1016/j.clml.2019.09.094
- By:
- Publication type:
- Article
Synthetic lethality in multiple myeloma harboring double oncogenic hits of 17p13(del) and 1q21(amp).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e50, doi. 10.1016/j.clml.2019.09.077
- By:
- Publication type:
- Article
REIIBP is a histone methyltransferase overexpressed in T(4;14) multiple myeloma with oncogenic potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e20, doi. 10.1016/j.clml.2019.09.029
- By:
- Publication type:
- Article
Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Addressing Unmet Medical Needs in Maintenance Treatment for Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S248, doi. 10.1016/j.clml.2018.07.147
- By:
- Publication type:
- Article
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.
- Published in:
- 2018
- By:
- Publication type:
- journal article
REIIBP is a Histone Methyltransferase Overexpressed in T(4;14) Multiple Myeloma with Oncogenic Potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e53, doi. 10.1016/j.clml.2017.03.097
- By:
- Publication type:
- Article
Recurrent Chromosome Abnormalities Define Nonoverlapping Unique Subgroups of Tumors in Patients With Chronic Lymphocytic Leukemia and Known Karyotypic Abnormalities.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 467, doi. 10.1016/j.clml.2013.05.003
- By:
- Publication type:
- Article
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01437-0
- By:
- Publication type:
- Article
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip.
- Published in:
- NPJ Precision Oncology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41698-019-0102-5
- By:
- Publication type:
- Article